This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Graham Ilsley
Vice President & Head Global Clinical Delivery at Covance, UK

Profile

Graham Ilsley, based in Maidenhead, joined Covance in 2003 as a Project Director and gained leadership experience across several global studies across a broad range of key therapeutic areas before assuming the role of Director Clinical Operations, Northern European in 2004.

From 2007-2011, Graham served Covance as Executive Director for Global Operations Resource Management, Graham’s global leadership in designing the first CDS Resource Management team, our forecasting tool, and our process and communication pathway was a key contributor to our ability to recruit the necessary talent required as we were growing and securing several new strategic client relationships while also growing our profitability.

During 2011 -2012, Graham continued to broaden his leadership as Executive Director of our global PMO within Project Management. In this role, Graham led the process innovation, staffing and recruiting needed to establish the PMO as a major organization improving the quality, metrics, financial performance and oversight of all CDS studies we conduct on behalf of our clients.

In 2013, having served 4 months as an interim leader and GLT member for Global Project Management, Global Site Services, Global Regulatory Submissions and the PMO, Graham was promoted to Vice President, Global PMO with responsibilities for The PMO, Global Site Services, Global Vendor Management, Clinical and Ancillary Supplies, Adjudication, Quality Control and Business & Process Solutions.

In 2015 Graham took on the Alliance Lead role for Bayer and served as Executive Sponsor for the AZ SAMM relationship.  In October 2016 Graham moved into the corporate Alliance Management team and assumed enterprise-wide alliance management responsibilities for both Bayer and Astra Zeneca.

In June 2018 Graham was asked to take on the role of Head, Global Clinical Delivery on an interim basis and in October 2018 assumed the role permanently.

Prior to joining Covance, Graham developed pre-clinical, CRA and senior PM experience with Smith-Kline Beecham, Innovex and GlaxoWellcome.  Graham also gained entrepreneurial management experience as Program Performance Director of a venture capital funded secondary-care site management organization (SMO), Intercern, in the U.K.  Graham obtained his degree in Applied Biology from the University of Wales Institute of Science and Technology in 1989.

Agenda Sessions

  • Managing complexity: COVID-19 road to recovery

    15:25
  • Managing complexity: COVID-19 road to recovery

    15:25